The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.
Ayumi KataokaMasataka SawakiNanae HorisawaHaruru KotaniAkiyo YoshimuraMasaya HattoriYayoi AdachiKayoko SuginoYuka EndoYuri OzakiEiichi SasakiWaki HosodaHiroji IwataPublished in: Annals of surgical oncology (2023)
The absence of cancer in the location of a breast tissue marker after NAC predicted pCR with high accuracy. Therefore, the rebiopsy of a marker's location might mean surgery is unnecessary.